CVS Health topped earnings estimates and lifted 2026 guidance but warned of 2027 headwinds from Caremark membership declines.
CVS Health reported quarterly earnings above expectations and raised its 2026 EPS guidance, citing strong performance across its segments. The company now projects 2026 earnings per share above prior forecasts, though shares pared early gains after the announcement.
Management highlighted near-term strength but cautioned over 2027 EPS projections, which align with consensus estimates. A decline in Caremark membership and rising operational costs were flagged as key risks, introducing uncertainty beyond the current year.
Oil prices edged lower despite heightened geopolitical tensions after Houthi attacks on Saudi oil vessels. Diplomatic efforts to reopen the Strait of Hormuz may ease supply concerns, though risks to crude markets persist.